Skip to main content
Contact Us
Subscribe
E-Edition
83°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
Next >
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
April 24, 2024
Tags
Congress
Politics
Policy
From
CNBC.com News
More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says
April 24, 2024
Tags
US: News
Novo Nordisk A/S
Business News
From
CNBC.com News
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
April 20, 2024
Tags
Portillos Inc
Eli Lilly and Co
Novo Nordisk A/S
From
CNBC.com News
Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says
April 17, 2024
Tags
Novo Nordisk A/S
US: News
Eli Lilly and Co
From
CNBC.com News
Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials
April 17, 2024
Tags
Pharmaceuticals
Health & Science
Novo Nordisk A/S
From
CNBC.com News
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts
April 12, 2024
Tags
Novo Nordisk A/S
US: News
Eli Lilly and Co
From
CNBC.com News
Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial
April 04, 2024
Tags
Eli Lilly and Co
US: News
Novo Nordisk A/S
From
CNBC.com News
Danone CEO downplays threat of weight loss drugs on food producers: 'We see ourselves as extremely complementary'
April 04, 2024
Tags
Europe News
Food and drink
Business
From
CNBC.com News
Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
April 03, 2024
Tags
Novo Nordisk A/S
Eli Lilly and Co
Biotech and Pharmaceuticals
From
CNBC.com News
Altimmune says weight loss drug minimized muscle loss in trial results that may set it apart
March 27, 2024
Tags
Companies
Business
Health care industry
From
CNBC.com News
Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests
March 27, 2024
Tags
Health & Science
Pharmaceuticals
Business
From
CNBC.com News
Viking Therapeutics stock jumps 15% on promising weight loss pill data
March 26, 2024
Tags
Novo Nordisk A/S
Eli Lilly and Co
US: News
From
CNBC.com News
Amgen wants in on the booming weight loss drug market — and it's taking a different approach
March 24, 2024
Tags
Science
Business News
Biotechnology
From
CNBC.com News
Two fresh ways to play the weight loss and megacap tech hype
March 23, 2024
Tags
ETF Edge
Breaking News: Markets
Microsoft Corp
From
CNBC.com News
Here's how much people are willing to spend on weight loss drugs, according to a new survey
March 23, 2024
Tags
Companies
Pharmaceuticals
Health & Science
From
CNBC.com News
Cramer's Lighting Round: Arm is a buy
March 22, 2024
Tags
Raymond James Financial Inc
Investment strategy
Business
From
CNBC.com News
Medicare can now cover certain weight loss drugs in a big step for patients
March 21, 2024
Tags
Companies
Pharmaceuticals
Health & Science
From
CNBC.com News
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
March 19, 2024
Tags
Health & Science
Viking Therapeutics Inc
Madrigal Pharmaceuticals Inc
From
CNBC.com News
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
March 16, 2024
Tags
Labor economy
Social issues
Novo Nordisk A/S
From
CNBC.com News
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
March 14, 2024
Tags
Biotech and Pharmaceuticals
Biotechnology
Breaking News: Business
From
CNBC.com News
Weight Watchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit
March 14, 2024
Tags
Weight loss diets
Eli Lilly and Co
Obesity
From
CNBC.com News
Experts hesitate on weight loss ETFs amid the obesity drug boom
March 13, 2024
Tags
Investment strategy
Health care industry
Health
From
CNBC.com News
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients
March 13, 2024
Tags
Health & Science
Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
Jim Cramer reviews Citi's European 'Super Seven'
March 08, 2024
Tags
Citigroup Inc
stocks
Eaton Corporation PLC
From
CNBC.com News
Novo Nordisk's Wegovy wins FDA approval for heart health benefits, in move that could expand insurance coverage
March 08, 2024
Tags
Breaking News: Business
Business News
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk CEO says experimental weight loss pill could become a best in class drug
March 08, 2024
Tags
Health care industry
Business
Pharmaceuticals
From
CNBC.com News
Novo Nordisk market cap surpasses Tesla on new obesity pill trial data
March 08, 2024
Tags
Pharmaceuticals
Europe Markets
Europe News
From
CNBC.com News
Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips
March 07, 2024
Tags
Breaking News: Markets
Biotech and Pharmaceuticals
Breaking News: Investing
From
CNBC.com News
Novo Nordisk's diabetes drug Ozempic slashed the risk of kidney disease progression in trial
March 05, 2024
Tags
Health & Science
Pharmaceuticals
US: News
From
CNBC.com News
Cramer says get ready to buy if there's a market sell-off: 'I have my shopping list'
March 04, 2024
Tags
Mad Money
Stock markets
U/S/ Markets
From
CNBC.com News
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.